drugset / Trial / NCT03106740

Evaluating the Role of Neuroinflammation in Low Back Pain

NCT03106740 ↗

RandomizedParallel-groupQuadruple-blindBasic science

Summary

In this research, the study team will use brain imaging to evaluate the presence of neuroinflammation in the brains and spinal cords of patients with low back pain. The efficacy of minocycline use for low back pain treatment will also be evaluated by observing whether short-term minocycline administration will reduce neuroinflammation and low back pain symptoms.

Timeline

Start
2017-10-10
Primary completion
2024-04-30
Completion
2024-04-30

Outcome

Missed primary endpoint

registry analysis (superiority test); Minocycline Arm vs Placebo Arm; p = 0.956; NCT03106740 ↗

paper The mean thalamic positron emission tomography standard uptake value ratio was very stable across visits in both groups, with no significant group-by-time interaction (P = 0.956). PMID 40839604 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Minocycline Small molecule 100 mg Oral

Indications